DISCUSSION
stroke, cerebrovascular diseases, diabetes
MSU, CEREBROVASCULAR DISEASES, STROKE, DIABETES
This study presents the findings of a prospective trial that aimed to compare the outcomes of patients diagnosed with AIS receiving care either from a 5G MSU or an EMS. To ensure comparability, the study ensured that the baseline characteristics of patients in both groups were similar, with the exception of diabetes. Data were collected over a 90‐day follow‐up period. The results demonstrated that patients in the MSU group exhibited lower mRS scores at 90 days, as well as at 7 days for both mRS and NIHSS scores. These findings suggest a more favorable prognostic outcome for patients in the MSU group compared to the EMS group. Additionally, the median time from symptom onset to thrombolysis was shorter in the MSU group, indicating a prompter administration of treatment. Furthermore, the study observed reduced hospitalization costs associated with MSU care.The findings of our study are in line with previous research in the field. Ebinger et al. (Although the average hospitalization cost in the MSU group was lower compared to the EMS group, the observed differences did not reach statistical significance. However, it is important not to overlook the efficacy of MSU in stroke management. Previous studies have demonstrated that the utilization of MSUs leads to improved quality‐adjusted life years for patients in comparison to EMS, indicating its potential as a cost‐effective option for patient care (Kim et al., One of the notable strengths of this study lies in the integration of 5G technology with MSUs, which opens up new possibilities for delivering emergency treatment to patients with stroke. However, several challenges remain that need to be effectively addressed during practical implementation. First, there is a need for further improvement in 5G technology infrastructure construction and the development of mobile stroke treatment teams. This includes ensuring the stability and safety of 5G transmission technology, as well as aligning the operation mode and qualification of 5G MSUs with existing local EMS. Second, additional research efforts are required to mitigate the misdiagnosis rates associated with 5G technology in stroke emergencies. Moreover, addressing staffing issues within MSUs due to the shortage of specialists in cerebrovascular diseases is crucial. Finally, exploring novel models for utilizing 5G MSUs, such as performing surgical procedures through 5G technology within the MSUs, and effectively integrating 5G MSUs into overall medical emergency management are avenues worth exploring.Several limitations should be acknowledged in this study. First, the absence of randomization in the trial design may have led to biased treatment assignments, potentially impacting the internal validity of the findings. Second, the evaluation of patients through the WeChat app on the phone introduced limitations in data accuracy compared to face‐to‐face communication. However, efforts were made to mitigate this risk by maintaining standardized records. Additionally, although the number of missing follow‐up data was small, there remains a certain risk of bias associated with these missing data. Lastly, the single‐center nature of the trial and the relatively small sample size restrict the generalizability and external validity of the results, warranting caution when interpreting the findings in a broader context.